deltatrials
Active Not Recruiting NA INTERVENTIONAL 2-arm NCT04192747

The Elixir Bioadaptor vs. The Onyx Stent in De Novo Native Coronary Arteries (BIOADAPTOR RCT)

Evaluation of a Sirolimus Eluting Bioadaptor as Compared to a Zotarolimus Eluting Stent in De Novo Native Coronary Arteries ELX-CL-1805

Sponsor: Elixir Medical Corporation

Updated 20 times since 2020 Last updated: Mar 17, 2025 Started: Dec 16, 2020 Primary completion: Feb 28, 2023 Completion: Feb 28, 2027
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Coronary Artery Disease and Coronary Artery Stenosis, this trial is ongoing. The trial is conducted by Elixir Medical Corporation and has accumulated 20 data snapshots since 2020. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

~Jan 2020 – ~Feb 2020 · 31 days · monthly snapshot~Feb 2020 – ~Mar 2020 · 29 days · monthly snapshot~Mar 2020 – ~May 2020 · 2 months · monthly snapshot~May 2020 – ~Jun 2020 · 31 days · monthly snapshot~Jun 2020 – ~Oct 2020 · 4 months · monthly snapshot~Oct 2020 – ~Jan 2021 · 3 months · monthly snapshot~Jan 2021 – ~Feb 2021 · 31 days · monthly snapshot~Feb 2021 – ~Mar 2021 · 28 days · monthly snapshot~Mar 2021 – ~May 2021 · 2 months · monthly snapshot~May 2021 – ~Sep 2021 · 4 months · monthly snapshot~Sep 2021 – ~Nov 2021 · 2 months · monthly snapshot~Nov 2021 – ~Feb 2022 · 3 months · monthly snapshot~Feb 2022 – ~Sep 2022 · 7 months · monthly snapshot~Sep 2022 – ~Oct 2023 · 13 months · monthly snapshot~Oct 2023 – ~Jul 2024 · 9 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Nov 2024 · 2 months · monthly snapshot~Nov 2024 – ~Apr 2025 · 5 months · monthly snapshot~Apr 2025 – ~Sep 2025 · 5 months · monthly snapshot~Sep 2025 – present · 10 months · monthly snapshot

Change History

20 versions recorded
  1. Sep 2025 — Present [monthly]

    Active Not Recruiting NA

  2. Apr 2025 — Sep 2025 [monthly]

    Active Not Recruiting NA

  3. Nov 2024 — Apr 2025 [monthly]

    Active Not Recruiting NA

  4. Sep 2024 — Nov 2024 [monthly]

    Active Not Recruiting NA

  5. Jul 2024 — Sep 2024 [monthly]

    Active Not Recruiting NA

Show 15 earlier versions
  1. Oct 2023 — Jul 2024 [monthly]

    Active Not Recruiting NA

  2. Sep 2022 — Oct 2023 [monthly]

    Active Not Recruiting NA

    Status: RecruitingActive Not Recruiting

  3. Feb 2022 — Sep 2022 [monthly]

    Recruiting NA

  4. Nov 2021 — Feb 2022 [monthly]

    Recruiting NA

  5. Sep 2021 — Nov 2021 [monthly]

    Recruiting NA

  6. May 2021 — Sep 2021 [monthly]

    Recruiting NA

  7. Mar 2021 — May 2021 [monthly]

    Recruiting NA

  8. Feb 2021 — Mar 2021 [monthly]

    Recruiting NA

  9. Jan 2021 — Feb 2021 [monthly]

    Recruiting NA

    Status: Not Yet RecruitingRecruiting

  10. Oct 2020 — Jan 2021 [monthly]

    Not Yet Recruiting NA

  11. Jun 2020 — Oct 2020 [monthly]

    Not Yet Recruiting NA

  12. May 2020 — Jun 2020 [monthly]

    Not Yet Recruiting NA

  13. Mar 2020 — May 2020 [monthly]

    Not Yet Recruiting NA

  14. Feb 2020 — Mar 2020 [monthly]

    Not Yet Recruiting NA

  15. Jan 2020 — Feb 2020 [monthly]

    Not Yet Recruiting NA

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Elixir Medical Corporation
Data source: Elixir Medical Corporation

For direct contact, visit the study record on ClinicalTrials.gov .